Search our Database of Scientific Publications and Authors

I’m looking for a
    Autophagy and polyglutamine diseases.
    Prog Neurobiol 2012 May 10;97(2):67-82. Epub 2011 Sep 10.
    Department of Medical Genetics, Cambridge Institute for Medical Research, Addenbrooke's Hospital, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
    In polyglutamine diseases, an abnormally elongated polyglutamine tract results in protein misfolding and accumulation of intracellular aggregates. The length of the polyglutamine expansion correlates with the tendency of the mutant protein to aggregate, as well as with neuronal toxicity and earlier disease onset. Although currently there is no effective cure to prevent or slow down the progression of these neurodegenerative disorders, increasing the clearance of mutant proteins has been proposed as a potential therapeutic approach. The ubiquitin-proteasome system and autophagy are the two main degradative pathways responsible for eliminating misfolded and unnecessary proteins in the cell. We will review some of the studies that have proposed autophagy as a strategy to reduce the accumulation of polyglutamine-expanded protein aggregates and protect against mutant protein neurotoxicity. We will also discuss some of the currently known mechanisms that induce autophagy, which may be beneficial for the treatment of these and other neurodegenerative disorders.

    Similar Publications

    Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases.
    Brain Res Rev 2008 Nov 23;59(1):245-52. Epub 2008 Aug 23.
    Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
    A number of neurodegenerative diseases, including Alzheimer's, Parkinson's, and polyglutamine diseases, are characterized by the age-dependent formation of intracellular protein aggregates and neurodegeneration. Although there is some debate surrounding the role of these aggregates in neurotoxicity, the formation of aggregates is known to reflect the accumulation of misfolded and toxic proteins. The degradation of misfolded proteins occurs mainly via the ubiquitin-proteasome and autophagy pathways. Read More
    Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
    Curr Top Dev Biol 2006 ;76:89-101
    Department of Medical Genetics Cambridge Institute for Medical Research Addenbrooke's Hospital, Cambridge CB2 2XY United Kingdom.
    Intracellular protein misfolding/aggregation are features of many late-onset neurodegenerative diseases, called proteinopathies. These include Alzheimer's disease, Parkinson's disease, tauopathies, and polyglutamine expansion diseases [e.g. Read More
    HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.
    Nature 2007 Jun;447(7146):859-63
    Department of Neurology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
    A prominent feature of late-onset neurodegenerative diseases is accumulation of misfolded protein in vulnerable neurons. When levels of misfolded protein overwhelm degradative pathways, the result is cellular toxicity and neurodegeneration. Cellular mechanisms for degrading misfolded protein include the ubiquitin-proteasome system (UPS), the main non-lysosomal degradative pathway for ubiquitinated proteins, and autophagy, a lysosome-mediated degradative pathway. Read More
    Na+/H+ exchangers induce autophagy in neurons and inhibit polyglutamine-induced aggregate formation.
    PLoS One 2013 21;8(11):e81313. Epub 2013 Nov 21.
    Department of Peripheral Nervous System Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan.
    In polyglutamine diseases, an abnormally elongated polyglutamine results in protein misfolding and accumulation of intracellular aggregates. Autophagy is a major cellular degradative pathway responsible for eliminating unnecessary proteins, including polyglutamine aggregates. Basal autophagy constitutively occurs at low levels in cells for the performance of homeostatic function, but the regulatory mechanism for basal autophagy remains elusive. Read More